ASPD blunts the effects of HIV and antiretroviral treatment on event-related brain potentials

Neuropsychobiology

Volumn 53, Issue 1, 2006, Pages 17-25

  Bauer, Lance O ^a,b   Shanley, John D ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Antisocial personality disorder; HIV 1; Substance dependence

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AMPLITUDE MODULATION; ANALYSIS OF COVARIANCE; ARTICLE; BRAIN FUNCTION; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; EVENT RELATED POTENTIAL; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOPATHY; STATISTICAL SIGNIFICANCE; TOPOGRAPHY;

ADULT; ANALYSIS OF VARIANCE; ANTI-RETROVIRAL AGENTS; ANTISOCIAL PERSONALITY DISORDER; EVENT-RELATED POTENTIALS, P300; FEMALE; FRONTAL LOBE; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS;

EID: 32844460653     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200610001-00054     Document Type: Article

References (44)

1. Stout JC, Ellis RJ, Jernigan TL, Archibald SL, Abramson I, Wolfson T, McCutchan JA, Wallace MR, Atkinson JH, Grant I: Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. Arch Neurol 1998;55:161-168.
2. Goodkin K, Wilkie FL, Concha M, Asthana D, Shapshak P, Douyon R, Fujimura RK, LoPiccolo C: Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection. Neuroradiological, neurophysiological, neuroimmunological, and virological correlates. Neuroimaging Clin N Am 1997;7:561-569.
3. Wilkie FL, Goodkin K, van Zuilen MH, Tyll MD, Lecusay R, Edwin T: Cognitive effects of HIV-1 infection. CNS Spectr 2000;5:33-54.
4. Syndulko K, Singer EJ, Nogales-Gaete J, Conrad A, Schmid P, Tourtellotte WW: Laboratory evaluations in HIV-1-associated cognitive/motor complex. Psychiatr Clin North Am 1994;17:91-123.
5. Clark VP, Fannon S, Lai S, Benson R, Bauer LO: Responses to rare visual target and distractor stimuli using event-related fMRI. J Neurophysiol 2000;83:3133-3139.
6. Bledowski C, Prvulovic D, Hoechstetter K, Scherg M, Wibral M, Goebel R, Linden DE: Localizing P300 generators in visual target and distractor processing: a combined event related potential and functional magnetic resonance imaging study. J Neurosci 2004;24:9353-9360.
7. Rangaswamy M, Porjesz B, Ardekani BA, Choi SJ, Tanabe JL, Lim KO, Begleiter H: A functional MRI study of visual oddball: evidence for frontoparietal dysfunction in subjects at risk for alcoholism. Neuroimage 2004;21:329-339.
8. Goodin DS, Aminoff MJ, Chernoff DN, Hollander H: Long latency event related potentials in patients infected with human immunodeficiency virus. Ann Neurol 1990;27:414-419.
9. Ollo C, Johnson R, Grafman J: Signs of cognitive change in HIV disease: an event related brain potential study. Neurology 1991;41:209-215.
10. Aznar-Bueno C, Abad-Alegria F, Amiguet JA: Early detection of neurophysiological abnormalities in infection by human immunodeficiency virus. Clin Electroencephalogr 2000;31:116-121.
11. Linnville SE, Elliott FS, Larson GE: Event related potentials as indices of subclinical neurological differences in HIV patients during rapid decision making. J Neuropsychiatry Clin Neurosci 1996;8:293-304.
12. Messenheimer JA, Robertson KR, Wilkins JW, Kalkowski JC, Hall CD: Event related potentials in human immunodeficiency virus infection. Arch Neurol 1992;49:396-400.
13. Polich J, Ilan A, Poceta JS, Mitler MM, Darko DF: Neuroelectric assessment of HIV: EEG, ERP, and viral load. Int J Psychophysiol 2000;38:97-108.
14. Grotemeyer KH, Husstedt IW, Brundermann H, Busch H, Schlake HP, Zidek W: Event-related potential in HIV-infected outpatients. AIDS Res Hum Retroviruses 1991;7:629-635.
15. Ragazzoni A, Grippo A, Ghidini P, Schiavone V, Lolli F, Mazzotta F, Mecocci L, Pinto F: Electrophysiological study of neurologically asymptomatic HIV-1 seropositive patients. Acta Neurol Scand 1993;87:47-51.
16. Portegies P, De Gans J, Lang JMA: Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. BMJ 1989;299:819-821.
17. Sacktor N: The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 2002;8:115-121.
18. Husstedt IW, Frohne L, Bockenholt S, et al: Impact of highly active antiretroviral therapy on cognitive processing in HIV infection: cross-sectional and longitudinal studies of event related potentials. AIDS Res Hum Retroviruses 2002;18:485-490.
19. Evers S, Grotemeyer KH, Reichelt D, Luttman S, Husstedt IW: Impact of antiretroviral treatment on AIDS dementia: a longitudinal prospective event related potential study. J Acquir Immune Defic Syndr Human Retrovirol 1998;17:143-148.
20. Gill K, Nolimal D, Crowley TJ: Antisocial personality disorder, HIV risk behavior and retention in methadone maintenance therapy. Drug Alcohol Depend 1992;30:247-252.
21. Brooner RK, Bigelow GE, Strain E, Schmidt CW: Intravenous drug abusers with antisocial personality disorder: increased HIV risk behavior. Drug Alcohol Depend 1990;26:39-44.
22. Brooner RK, Greenfield L, Schmidt CW, Bigelow GE: Antisocial personality disorder and HIV infection among intravenous drug abusers. Am J Psychiatry 1993;150:53-58.
23. Bauer LO, Houston RJ: Neurophysiological and cognitive correlates of antisocial behavior; in Fishbein D (ed): The Science, Treatment, and Prevention of Antisocial Behavior. Kingston, Civic Research Institute, 2004, chapter 5, pp 96-124.
24. Bauer LO, O'Connor S, Hesselbrock VM: Frontal P300 decrements in antisocial personality disorder. Alcohol Clin Exp Res 1994;18:1300-1305.
25. Bauer LO: Frontal P300 decrements, childhood conduct disorder, family history, and the prediction of relapse among abstinent cocaine abusers. Drug Alcohol Depend 1997;44:1-10.
26. Costa L, Bauer L, Kuperman S, Porjesz B, O'Connor S, Hesselbrock V, Rohrbaugh J, Begleiter H: Frontal P300 decrements, alcohol dependence, and antisocial personality disorder. Biol Psychiatry 2000;47:1064-1071.
27. Raine A, Buchsbaum MA, Stanley J, Lottenberg S, Abel L, Stoddard J: Selective reductions in prefrontal glucose metabolism in murderers. Biol Psychiatry 1994;36:365-373.
28. Kuruoglu AC, Arikan Z, Vural G, Karatas M, Arac M, Isik E: Single photon emission computerized tomography in chronic alcoholism: antisocial personality disorder may be associated with decreased frontal perfusion. Br J Psychiatry 1996;169:348-354.
29. Raine A, Lencz T, Bihrle S, LaCasse L, Colletti P: Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder. Arch Gen Psychiatry 2000;57:119-127.
30. Gillen R, Hesselbrock VM: Cognitive functioning, ASP, and a family history of alcoholism in young men at risk for alcoholism. Alcohol Clin Exp Res 1992;16:206-214.
31. Goldstein RB, Bigelow C, McCusker J, Lewis BF, Mundt KA, Powers SI: Antisocial behavioral syndromes and return to drug use following residential relapse prevention/health education treatment. Am J Drug Alcohol Abuse 2001;27:453-482.
32. Grella CE, Joshi V, Hser YI: Follow-up of cocaine dependent men and women with antisocial personality disorder. J Subst Abuse Treat 2003;25:155-164.
33. Leal J, Ziedonis D, Kosten T: Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence. Drug Alcohol Depend 1994;35:31-35.
34. Compton WM, Cottler LB, Ben-Abdallah A, Cunningham-Williams R, Spitznagel EL: The effects of psychiatric comorbidity on response to an HIV prevention intervention. Drug Alcohol Depend 2000;58:247-257.
35. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
36. Robins LN, Cottler LB, Bucholz KK, Compton WM, North CS, Rourke KM: Diagnostic Interview Schedule for the DSM-IV (DIS-IV). St. Louis, Washington University, 2002.
37. McLellan AT, Luborsky L, Woody GE, O'Brien CP: An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index. J Nerv Ment Dis 1980;168:26-33.
38. Selzer ML: The Michigan Alcoholism Screening Test: the quest for a new diagnostic instrument. Am J Psychiatry 1971;127:1653-1658.
39. Skinner HA: The drug abuse screening test. Addict Behav 1982;7:363-371.
40. Beck AT, Steer RA, Brown GK: Beck Depression Inventory, version II manual. San Antonio, Psychological Corporation/Harcourt Brace, 1996.
41. Kaufman AS, Kaufman NL: Kaufman Brief Intelligence Test. Circle Pines, American Guidance Services, 1990.
42. Fuchs M, Drenckhahn R, Wischmann HA, Wagner M: Bioelectric and biomagnetic reconstructions with an improved boundary element method for realistic volume conductor modeling. IEEE Trans Biomed Eng 1998;45:980-997.
43. Hjorth B: Source derivation simplifies topographical EEG interpretation. Am J EEG Technol 1980;20:121-132.
44. Blair RJ: Neurocognitive models of aggression, the antisocial personality disorders, and psychopathy. J Neurol Neurosurg Psychiatry 2001;71:727-731.